MeMed
MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
About
MeMed is a leading med tech and bio-convergence company focused on developing and commercializing innovative host immune response testing methods. Their mission is to translate the complex signals of the immune system into simple diagnostic insights, helping clinicians make better decisions for patients facing acute infections and inflammatory conditions. Teams look it up for Healthcare, Blood, Diagnostics.
Frequently asked
What does MeMed do?
MeMed is a Healthcare company that offers Software, Hardware. Teams look it up for Blood, Diagnostics, MedTech. It is based in Tirat Carmel, Israel and was founded in 2009. Public records show about 99 people and $196M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has MeMed raised?
MeMed has raised a total of $196M in funding. The most recent round on record is Series E.
Where is MeMed headquartered?
MeMed is headquartered in Tirat Carmel, Israel.
When was MeMed founded?
MeMed was founded in 2009.
What industry does MeMed operate in?
MeMed operates in Healthcare, Blood, Diagnostics, MedTech, Biotech.
How many employees does MeMed have?
MeMed has approximately 99 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.